Notable Labs Announces Partnership with myTomorrows

“As an established player in the preapproval access space, we are excited to broaden our reach by partnering with Notable,” said Michel van Harten, chief operating officer of myTomorrows. “We look forward to supporting more patients with critical information on treatment options and providing a pathway to access those treatments.”

FREMONT, CA: Notable, a functional precision medicine company, and myTomorrows, an integrated platform that links patients with an unmet medical need to treatments in development worldwide, announced a strategic partnership.

“We are thrilled to partner with myTomorrows in support of our shared mission of helping patients,” stated Hiroomi Tada, M.D., Ph.D., chief medical officer of Notable. “Our goal is to provide meaningful information and treatment options to myTomorrows to share with patients in their network for whom standard treatments have been exhausted.”

Clinical researchers and physicians collaborating with Notable can be referred to myTomorrows to investigate preapproval treatment options for their patients. Patients can also be directly referred to myTomorrows’ platform to find and look for access to preapproval treatment options. In parallel, myTomorrows will streamline appropriate physician and patient referrals to Notable to utilize their testing platform to find out potential clinical studies that are being conducted in collaboration with researchers in Notable’s network. myTomorrows may further help physicians at these partner institutions in finding options for their other patients.

“As an established player in the preapproval access space, we are excited to broaden our reach by partnering with Notable,” said Michel van Harten, chief operating officer of myTomorrows. “We look forward to supporting more patients with critical information on treatment options and providing a pathway to access those treatments.”